User menu

Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer

Bibliographic reference Van Cangh, Paul ; De Nayer, Philippe ; Sauvage, P. ; Tombal, Bertrand ; Elsen, M. ; et. al. Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.1st International Consultation on Prostate Cancer (Monte Carlo (Monaco), Jun 20-22, 1996). In: The Prostate, p. 30-34 (1996)
Permanent URL http://hdl.handle.net/2078.1/62821
  1. Lilja, Clin Chem, 37, 1618 (1991)
  2. Bangma, Urology, 46, 773 (1995)
  3. Catalona, JAMA, 274, 1214 (1995)
  4. Luderer, Urology, 46, 187 (1995)
  5. McCormack, Urology, 45, 729 (1995)
  6. Oesterling, J Urol, 154, 1090 (1995)
  7. Zweig, Clin Chem, 39, 561 (1993)